SFX-01 After Subarachnoid Haemorrhage

Clinical trial NCT02614742 · COMPLETED

Trial details

NCT number: NCT02614742
Sponsor: Evgen Pharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Subarachnoid Hemorrhage, Spontaneous

Start date: 2016-04-01
Primary completion: 2019-09-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.